A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable
Clinical trial NCT03428100 · COMPLETED
Trial details
- NCT number
- NCT03428100
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2019-11-25
- Enrollment
- 463
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.